Status:
ACTIVE_NOT_RECRUITING
cOCT Versus LC-OCT for Diagnosing Basal Cell Carcinoma: a Diagnostic Cohort Study
Lead Sponsor:
Maastricht University Medical Center
Conditions:
Basal Cell Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
Basal cell carcinoma (BCC) is the most common form of cancer among the Caucasian population. Equivocal BCC lesions are usually diagnosed by means of a punch biopsy, but since the last few decades, non...
Eligibility Criteria
Inclusion
- Patients (18+) with equivocal BCC lesions undergoing biopsy conform regular care
Exclusion
- Patients unable to sign informed consent
- Patients with clinically evident BCC lesions who do not undergo biopsy
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2024
Estimated Enrollment :
197 Patients enrolled
Trial Details
Trial ID
NCT06024629
Start Date
September 1 2023
End Date
September 1 2024
Last Update
February 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht UMC+
Maastricht, Netherlands